Many of America’s poorest and sickest patients are stuck navigating two separate insurance programs — Medicare and Medicaid — to get the care they need.
Insurance
Experts Share Four Key Studies you Might have Missed this Summer
Experts from the Tradeoffs Advisory Board share some of their favorite new health policy studies.
Can Medicare Afford to Foot the Bill for New Alzheimer’s Drugs?
Recent analyses in JAMA and by the Kaiser Family Foundation raise questions about whether Medicare and its beneficiaries can afford a new wave of Alzheimer’s treatments.
One Economist’s Plan to Blow Up America’s Health Insurance System
Economist Amy Finkelstein has studied America’s patchwork of health insurance policies for more than 20 years. She’s finally concluded that it’s time to tear the whole system down.
1.5 Million People Are Losing Medicaid. How Worried Should We Be?
We go behind the numbers of the first few months of the Medicaid unwinding.
The Meteoric Rise of Private Medicare Advantage Insurance
What’s gained and what’s lost as private insurers manage an increasingly large share of the Medicare program?
The ‘Reverse Disparity’ in Psychosis Care
We explore what it’s like to experience psychosis and why it can be so difficult for patients to get effective treatment.
The Wonky Policy That’s Got Hospitals on High Alert
Medicare could soon pay hospitals much less for common outpatient services like x-rays and checkups.
What we’ve learned from federal efforts to fight HIV/AIDS
A recent NBER working paper compares the impact of public health funding for HIV/AIDS to other federal programs.
Hospice Care’s Midlife Crisis
Medicare is testing some major changes to its 40-year-old hospice benefit.
